Sherbrooke Park Advisers LLC Trans Medics Group, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $436 Billion
- Q3 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 1,836 shares of TMDX stock, worth $147,761. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,836
Previous 3,617
49.24%
Holding current value
$147,761
Previous $545 Million
47.09%
% of portfolio
0.07%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding TMDX
# of Institutions
394Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$289 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$213 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$116 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$102 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$88.1 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.56B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...